BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8426740)

  • 1. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
    Fritsche M; Haessler C; Brandner G
    Oncogene; 1993 Feb; 8(2):307-18. PubMed ID: 8426740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage].
    Ceraline J; Deplanque G; Duclos B; Limacher JM; Vincent F; Goldblum S; Bergerat JP
    Bull Cancer; 1997 Nov; 84(11):1007-16. PubMed ID: 9536982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.v.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle.
    Yamaizumi M; Sugano T
    Oncogene; 1994 Oct; 9(10):2775-84. PubMed ID: 8084582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
    Rapisarda A; Melillo G
    Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
    Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT; Richardson DR
    Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis.
    Janson W; Brandner G; Siegel J
    Oncogene; 1997 Sep; 15(12):1395-406. PubMed ID: 9333015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ; Kim AL; Fine RL
    Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
    Denko NC; Green SL; Edwards D; Giaccia AJ
    Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y; McKalip A; Herman B
    J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.
    MacFarlane M; Jones NA; Dive C; Cohen GM
    Mol Pharmacol; 1996 Oct; 50(4):900-11. PubMed ID: 8863836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N; Friedlander P; Chen X; Prives C
    Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
    Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation.
    Li G; Ho VC
    Br J Dermatol; 1998 Jul; 139(1):3-10. PubMed ID: 9764141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RNA polymerase II as a trigger for the p53 response.
    Ljungman M; Zhang F; Chen F; Rainbow AJ; McKay BC
    Oncogene; 1999 Jan; 18(3):583-92. PubMed ID: 9989808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-damage-inducible p53 activity in SV40-transformed cells.
    Hess RD; Brandner G
    Oncogene; 1997 Nov; 15(20):2501-4. PubMed ID: 9395246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.